WS #7913

The dominant narrative from this window is a continuation of positive after-hours earnings and ASCO data releases, with several new high-significance developments. Workday (WDAY) rallied after results quieted fears of AI disruption, reinforcing the tech sector's resilience. IMAX is exploring a sale, per WSJ, sending shares higher. WhiteFiber surged on a $160M AI infrastructure deal. On the geopolitical front, an Ebola treatment hospital in DRC was burned down as the outbreak spreads, though the CDC states no US cases and low risk. The US is racing to create domestic rare earths supply, a bullish signal for critical minerals. Exxon Mobil is nearing a deal to re-enter Venezuela's oil sector, which could offset some supply tightness from the Ukrainian drone strike on the Lukoil-Kstovo refinery. The UK tightened oil and gas tax rules, closing a loophole for multinationals. Ross Stores raised its annual outlook as shoppers remain value-focused. Black Diamond Therapeutics reported positive Phase 2 results for silevertinib in NSCLC, with 15.2-month median PFS and 60% ORR. Akari Therapeutics stock rocketed 50% on KRAS combination data. Bioventus announced FDA reclassification of its Exogen system to Class II, with no material impact expected. The S&P SmallCap 600 index will add Universal Technical Institute and Peloton Interactive, replacing Veris Residential and Enviri. Overall, the earnings-driven positive sentiment, M&A activity (IMAX), and critical minerals policy support are the strongest signals, while geopolitical developments remain stable but with an escalating drone campaign against Russian refineries and a worsening Ebola outbreak in DRC.